Markets rallied sharply as easing US–Iran tensions and softer crude prices boosted sentiment. Sensex and Nifty surged 2%, adding Rs 10 lakh...

Indian benchmark indices ended marginally lower on Friday as investors assessed the RBI’s decision to keep rates unchanged while raising in...

Prime Focus shares saw a rise on Friday. The company reported a profit of Rs 82 crore for the fourth quarter of FY26. This marks a signific...

According to Nuvama Alternative & Quantitative Research, the Indian stock market is set to witness a significant wave of lock-in expiries b...

Indian stock markets may appear stagnant, but opportunities exist in small and midcap stocks. JM Financial's Ashish Chaturmohta highlights ...

India’s stock market is set for a wave of IPO lock-in expiries over the next three months, with shares worth $34 billion from 73 recently l...

Expensive petrol is now encouraging Indian households to buy electric vehicles. Electric two-wheelers are seeing increased demand as fuel p...

Vehicle sales saw a significant 13% jump last month, reaching 2.61 million units. This surge marks the best-ever April for most vehicle cat...

As environmental consciousness rises, Indian consumers are increasingly opting for electric vehicles. Favorable state policies are making E...

The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...

The Centre has rejected Andhra Pradesh's plea to supply diesel at retail prices for Amaravati's construction. Union Petroleum Secretary Nee...

Sai Parenterals made its debut on Dalal Street with a slight uptick in share prices. Despite the company’s promising diversification in pha...

Sai Parenteral's IPO share allotment is expected today, with investors able to check their status on BSE or the registrar's website. The is...

Sai Parenteral's IPO opens for subscription, aiming to raise Rs 409 crore through a mix of fresh equity and an offer for sale. The company ...

Sai Life Sciences' Rs 3,042 crore IPO was oversubscribed 10.26 times at close, driven by institutional investors. The IPO, priced at Rs 522...

Sai Life Sciences' IPO, aiming to raise up to Rs 3,042 crore, includes a fresh equity issue of up to Rs 950 crore and an Offer for Sale of ...

"Signature Global has a history of losses and faces concentration risk and stiff competition from other developers. After this listing, inv...